GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
Junyi Chen,1,* Pinghua Yang,2,* Jue Yang,2 Zhijian Wen,2 Baohua Zhang,2 Xin Zheng1,3 1Department of General Surgery, Branch of the First People’s Hospital of Shanghai, 2Department of Hepatic Surgery, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 3Departme...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-12-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/git1-is-a-novel-prognostic-biomarker-and-facilitates-tumor-progression-peer-reviewed-article-OTT |